Colorectal cancer in Iran: Molecular epidemiology and screening strategies

Journal of Cancer Epidemiology

Volumn 2015, Issue , 2015, Pages

  Dolatkhah, Roya ^a   Somi, Mohammad Hossein ^a   Bonyadi, Mortaza Jabbarpour ^c   Asvadi Kermani, Iraj ^b   Farassati, Faris ^d   Dastgiri, Saeed ^b  

^a TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c UNIVERSITY OF TABRIZ   (Iran)

^d UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APC PROTEIN; B RAF KINASE; CARCINOEMBRYONIC ANTIGEN; EPIDERMAL GROWTH FACTOR RECEPTOR; K RAS PROTEIN; MISMATCH REPAIR PROTEIN; PROTEIN P53; TUMOR MARKER;

CANCER DIAGNOSIS; CANCER EPIDEMIOLOGY; CANCER INCIDENCE; CANCER PATIENT; CANCER PROGNOSIS; CANCER SCREENING; CANCER SURVIVAL; CHROMOSOMAL INSTABILITY; CHROMOSOME 18Q; COLORECTAL CANCER; DIETARY INTAKE; EARLY DIAGNOSIS; ETHNICITY; FAMILY HISTORY; GENE INACTIVATION; GENE MUTATION; GENETIC PREDISPOSITION; GEOGRAPHIC DISTRIBUTION; GROUPS BY AGE; HEREDITY; HETEROZYGOSITY LOSS; HUMAN; IRAN; MICROSATELLITE INSTABILITY; MOLECULAR EPIDEMIOLOGY; MOLECULAR GENETICS; PRIORITY JOURNAL; PROTO ONCOGENE; REVIEW; SURVIVAL RATE; SURVIVAL TIME; SYSTEMATIC REVIEW; TUMOR SUPPRESSOR GENE;

EID: 84947648692     PISSN: 16878558     EISSN: 16878566     Source Type: Journal    
DOI: 10.1155/2015/643020     Document Type: Review

References (54)

1. R. Ansari, M. Mahdavinia, A. Sadjadi et al., "Incidence and age distribution of colorectal cancer in Iran: results of a populationbased cancer registry," Cancer Letters, vol. 240, no. 1,pp. 143-147, 2006.
2. R. Mundade, T. F. Imperiale, L. Prabhu, P. J. Loehrer, and T. Lu, "Genetic pathways, prevention, and treatment of sporadic colorectal cancer," Oncogenesis, vol. 1, no. 6, pp. 400-406, 2014.
3. V. Stigliano, L. Sanchez-Mete, and A. Martayan, "Early-onset colorectal cancer: a sporadic or inherited disease?" World Journal of Gastroenterology, vol. 20, no. 35, pp. 12420-12430, 2014.
4. R. C. Heine-Bröring, R. M. Winkels, J. M. S. Renkema et al., "Dietary supplement use and colorectal cancer risk: a systematic review and meta-analyses of prospective cohort studies," International Journal of Cancer, 2014.
5. H. Brim, P. Mokarram, F. Naghibalhossaini et al., "Impact of BRAF, MLH1 on the incidence of microsatellite instability high colorectal cancer in populations based study,"Molecular Cancer, vol. 7, article 68, 2008.
6. M. van Engeland, M. P. Weijenberg, G. M. J. M. Roemen et al., "Effects of dietary folate and alcohol intake on promotermethylation in sporadic colorectal cancer: the Netherlands cohort study on diet and cancer," Cancer Research, vol. 63, no. 12, pp. 3133-3137, 2003.
7. R. G.Hardy, S. J.Meltzer, andJ.A. Jankowski, "ABCof colorectal cancer:molecular basis for risk factors," BritishMedical Journal, vol. 321, no. 7265, pp. 886-889, 2000.
8. C. N. Arnold,A.Goel,H. E. Blum, andC. R. Boland, "Molecular of colorectal cancer: implications for molecular diagnosis," Cancer, vol. 104, no. 10, pp. 2035-2047, 2005.
9. J. R. Jass, M. D. Walsh, M. Barker, L. A. Simms, J. Young, and B. A. Leggett, "Distinction between familial and sporadic forms of colorectal cancer showing DNA microsatellite instability," European Journal of Cancer, vol. 38, no. 7, pp. 858-866, 2002.
10. J. R. Jass, "Classification of colorectal cancer based on correlation of clinical, morphological and molecular features," Histopathology, vol. 50, no. 1, pp. 113-130, 2007.
11. K. Hemminki, X. Li, and C. Dong, "Second primary cancers after sporadic and familial colorectal cancer," Cancer Epidemiology Biomarkers and Prevention, vol. 10, no. 7, pp. 793-798, 2001.
12. S. Kirzin, L. Marisa, R. Guimbaud et al., "Sporadic early-onset colorectal cancer is a specific sub-type of cancer: a morphological, molecular and genetics study," PLoS ONE, vol. 9, no. 8, Article ID e103159, 2014.
13. R. Malekzadeh, F. Bishehsari, M. Mahdavinia, and R. Ansari, "Epidemiology and molecular genetics of colorectal cancer in Iran: a review," Archives of Iranian Medicine, vol. 12, no. 2, pp. 161-169, 2009.
14. D. Colussi, G. Brandi, F. Bazzoli, and L. Ricciardiello, "Molecular pathways involved in colorectal cancer: implications for disease behavior and prevention," International Journal of Molecular Sciences, vol. 14, no. 8, pp. 16365-16385, 2013.
15. S. Al-Sohaily, A. Biankin, R. Leong, M. Kohonen-Corish, and J. Warusavitarne, "Molecular pathways in colorectal cancer," Journal of Gastroenterology and Hepatology, vol. 27, no. 9, pp. 1423-1431, 2012.
16. C. Kin, E. Kidess, G. A. Poultsides, B. C. Visser, and S. S. Jeffrey, "Colorectal cancer diagnostics: biomarkers, cell-free DNA, circulating tumor cells and defining heterogeneous populations by single-cell analysis," Expert Review of Molecular Diagnostics, vol. 13, no. 6, pp. 581-599, 2013.
17. U. Malapelle, C. Carlomagno, C. De Luca, C. Bellevicine, and G. Troncone, "KRAS testing inmetastatic colorectal carcinoma: challenges, controversies, breakthroughs and beyond," Journal of Clinical Pathology, vol. 67, no. 1, pp. 1-9, 2014.
18. H.R.Hagland,M.Berg, I.W. Jolma, A. Carlsen, andK. Sreide, "Molecular pathways and cellular metabolism in colorectal cancer," Digestive Surgery, vol. 30, no. 1, pp. 12-25, 2013.
19. V. H. Chong, M. S. Abdullah, P. U. Telisinghe, and A. Jalihal, "Colorectal cancer: incidence and trend in Brunei Darussalam," Singapore Medical Journal, vol. 50, no. 11, pp. 1085-1089, 2009.
20. J. Jackson-Thompson, F. Ahmed, R. R. German, S.-M. Lai, and C. Friedman, "Descriptive epidemiology of colorectal cancer in the United States, 1998-2001," Cancer, vol. 107, no. 5, pp. 1103-1111, 2006.
21. P. S. Pahlavan and R. Kanthan, "The epidemiology and clinical findings of colorectal cancer in Iran," Journal of Gastrointestinal and Liver Diseases, vol. 15, no. 1, pp. 15-19, 2006.
22. F. Ruthotto, F. Papendorf, G. Wegener et al., "Participation in screening colonoscopy in first-degree relatives from patients with colorectal cancer," Annals of Oncology, vol. 18, no. 9, pp. 1518-1522, 2007.
23. A. S.Behl and S. D. Ramsey, "KRAS and BRAF mutation screening inmetastatic colorectal cancer costly in relation to benefits," Journal of the National Cancer Institute, vol. 104, no. 23, Article ID djs518, 2012.
24. M. Mohebbi, K. Nourijelyani, M. Mahmoudi et al., "Time to occurrence and age distribution of digestive cancers in northern Iran," Iranian Journal of Public Health, vol. 37, no. 1, pp. 8-19, 2008.
25. M. Barouni,M.H. Larizadeh, A. Sabermahani, and H. Ghaderi, "Markov's modeling for screening strategies for colorectal cancer," Asian Pacific Journal of Cancer Prevention, vol. 13, no. 10, pp. 5125-5129, 2012.
26. F. Hajmanoochehri, S. Asefzadeh, A. M. Kazemifar, and M. Ebtehaj, "Clinicopathological features of colon adenocarcinoma in Qazvin, Iran: a 16 year study," Asian Pacific Journal of Cancer Prevention, vol. 15, no. 2, pp. 951-955, 2014.
27. S. Kolahdoozan, A. Sadjadi, A. R. Radmard, and H. Khademi, "Five common cancers in Iran," Archives of Iranian Medicine, vol. 13, no. 2, pp. 143-146, 2010.
28. R. Ansari, H. Amjadi, N. Norozbeigi et al., "Survival analysis of colorectal cancer in patients underwent surgical operation in Shariati andMehr Hospital-Tehran, in a retrospective study," Govaresh, vol. 12, no. 1, pp. 7-15, 2007.
29. S. M. H. Emami, A. M. Fatemi, Z. Farajzadegan, and S. M. Movahed-Abtahi, "Epidemiology of colorectal cancer in Isfahan province," Govaresh, vol. 10, no. 3, pp. 134-139, 2005.
30. A. Moradi, M. Khayamzadeh, M. M. Guya et al., "Survival of colorectal cancer in Iran," Asian Pacific Journal of Cancer Prevention, vol. 10, no. 4, pp. 583-586, 2009.
31. M.R. Rouhollahi,M.A.Mohagheghi,N.Mohammadrezai et al., "Situation analysis of the national comprehensive cancer control program (2013) in the I. R. of Iran; assessment and recommendations based on the IAEA imPACT mission," Archives of Iranian Medicine, vol. 17, no. 4, pp. 222-231, 2014.
32. R.Mahmodlou, P.Mohammadi, and N. Sepehrvand, "Colorectal cancer in northwestern Iran," ISRN Gastroenterology, vol. 2012, Article ID968560, 4 pages, 2012.
33. A. Safaee, S. R. Fatemi, S. Ashtari, M. Vahedi, B. Moghimi-Dehkordi, and M. R. Zali, "Four years incidence rate of colorectal cancer in Iran: a survey of national cancer registry data-implications for screening," Asian Pacific Journal of Cancer Prevention, vol. 13, no. 6, pp. 2695-2698, 2012.
34. M.H. Somi, M. Golzari, S. Farhang, S. Naghashi, and L. Abdollahi, "Gastrointestinal cancer incidence in East Azerbaijan, Iran: update on 5 year incidence and trends," Asian Pacific Journal of Cancer Prevention, vol. 15, no. 9, pp. 3945-3949, 2014.
35. M. H. Somi, S. Farhang, S. K. Mirinezhad, S. Naghashi, M. Seif-Farshad, and M. Golzari, "Cancer in East Azerbaijan, Iran: results of a population-based cancer registry," Asian Pacific Journal of Cancer Prevention, vol. 9, no. 2, pp. 327-330, 2008.
36. International Agency for Research on Cancer (IARC), "GLOBOCAN," World Cancer Report, 2012, http://globocan .iarc.fr.
37. M.Mahdavinia, F. Bishehsari, R.Ansari et al., "Family history of colorectal cancer in Iran," BMC Cancer, vol. 5, article 112, 2005.
38. S. M. Mousavi, M. M. Gouya, R. Ramazani, M. Davanlou, N. Hajsadeghi, and Z. Seddighi, "Cancer incidence and mortality in Iran," Annals of Oncology, vol. 20, no. 3, pp. 556-563, 2009.
39. A. Sadjadi, R. Malekzadeh, M. H. Derakhshan et al., "Cancer occurrence in Ardabil: results of a population-based cancer registry from Iran," International Journal of Cancer, vol. 107, pp. 113-118, 2003.
40. S. Alireza, N. Mehdi, M. M. Ali, M.-J. Alireza, M. Reza, and D. M. Parkin, "Cancer occurrence in Iran in 2002, an international perspective," Asian Pacific Journal of Cancer Prevention, vol. 6, no. 3, pp. 359-363, 2005.
41. S. V. Hosseini, A. Izadpanah, and H. Yarmohammadi, "Epidemiological changes in colorectal cancern in Shiraz, Iran: 1980-2000," ANZ Journal of Surgery, vol. 74, no. 7, pp. 547-549, 2004.
42. B.Yazdizadeh, A. M. Jarrahi, H. Mortazavi, M. A. Mohagheghi, S. Tahmasebi, and A. Nahvijo, "Time trends in the occurrence of major GI cancers in Iran," Asian Pacific Journal of Cancer Prevention, vol. 6, no. 2, pp. 130-134, 2005.
43. M. S. Fazeli, M. G. Adel, and A. H. Lebaschi, "Colorectal carcinoma: a retrospective, descriptive study of age, gender, subsite, stage, and differentiation in iran from 1995 to 2001 as observed in Tehran University," Diseases of the ColonandRectum, vol. 50, no. 7, pp. 990-995, 2007.
44. S. Azadeh, B. Moghimi-Dehkordi, S. R. Fatemi, M. A. Pourhoseingholi, S. Ghiasi, and M. R. Zali, "Colorectal cancer in Iran: an epidemiological study," Asian Pacific Journal of Cancer Prevention, vol. 9, no. 1, pp. 123-126, 2008.
45. M. Shahrier and D. J. Ahnen, "Colorectal cancer survival in Europe: the Will Rogers phenomenon revisited," Gut, vol. 47, no. 4, pp. 463-464, 2000.
46. M. E. Akbari and Coworkers, Iran Cancer Report, Cancer Research Center, Shahid Beheshti University, Tehran, Iran, 2008.
47. M. M. Haghighi, M. Vahedi, S. R. Mohebbi, M. A. Pourhoseingholi, S. R. Fatemi, and M. R. Zali, "Comparison of survival between patients with hereditary non-polyposis colorectal cancer (HNPCC) and sporadic colorectal cancer," Asian Pacific Journal of Cancer Prevention, vol. 10, no. 3, pp. 209-212, 2009.
48. M. Aryaie, G. Roshandel, S. Semnani et al., "Predictors of colorectal cancer survival in golestan, Iran: a population-based study," Epidemiology and Health, vol. 35, Article ID e2013004, 2013.
49. R.M.Hoffman, D. K. Espey, R. L. Rhyne et al., "Colorectal cancer incidence and mortality disparities in NewMexico," Journal of Cancer Epidemiology, vol. 2014, Article ID 239619, 8 pages, 2014.
50. E. Borrandgrave;as, I. Jurado, I.Hernan et al., "Clinical pharmacogenomic testing of KRAS, BRAF and EGFRmutations by high resolution melting analysis and ultra-deep pyrosequencing," BMC Cancer, vol. 11, article 406, 2011.
51. F. Naghibalhossaini, H. M. Hosseini, P. Mokarram, and M. Zamani, "High frequency of genes' promoter methylation, but lack of BRAF V600EMutation among Iranian colorectal cancer patients," Pathology and Oncology Research, vol. 17, no. 4, pp. 819-825, 2011.
52. S. D. Richman, M. T. Seymour, P. Chambers et al., "KRAS and BRAF mutations in advanced colorectal cancer are associated with poor prognosis but do not preclude benefit from oxaliplatin or irinotecan: results from the MRC FOCUS trial," Journal of Clinical Oncology, vol. 27, no. 35, pp. 5931-5937, 2009.
53. F. Bishehsari,M.Mahdavinia, R.Malekzadeh et al., "Patterns of K-ras mutation in colorectal carcinomas from Iran and Italy (a Gruppo Oncologico dell'Italia Meridionale study): influence of microsatellite instability status and country of origin," Annals of Oncology, vol. 17, no. 7, pp. vii91-vii96, 2006.
54. S. Sobhani, M. Ghaffarpour, Z. Mostakhdemin Hosseini, F. Kamali, Z. Nour Mohammadi, and M. Houshmand, "The prevalence of common mutation frequency in KRAS codons 12, 13 in Iranian colorectal cancer patients," Genetics in the 3rd Millennium, vol. 8, no. 2, pp. 2011-2018, 2010.